254 related articles for article (PubMed ID: 19060553)
1. Costimulation targeting therapies in organ transplantation.
Gandhi AM; Fazli U; Rodina V; Qazi YA
Curr Opin Organ Transplant; 2008 Dec; 13(6):622-6. PubMed ID: 19060553
[TBL] [Abstract][Full Text] [Related]
2. Belatacept: a novel immunosuppressive agent for kidney transplant recipients.
Charpentier B
Expert Rev Clin Immunol; 2012 Nov; 8(8):719-28. PubMed ID: 23167683
[TBL] [Abstract][Full Text] [Related]
3. Biological agents in kidney transplantation: belatacept is entering the field.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Expert Opin Biol Ther; 2010 Oct; 10(10):1501-8. PubMed ID: 20726688
[TBL] [Abstract][Full Text] [Related]
4. Co-signals in organ transplantation.
Durrbach A; Francois H; Jacquet A; Beaudreuil S; Charpentier B
Curr Opin Organ Transplant; 2010 Aug; 15(4):474-80. PubMed ID: 20631615
[TBL] [Abstract][Full Text] [Related]
5. Rationale for using belatacept in combination with sirolimus.
Wéclawiak H; Kamar N; Ould-Mohamed A; Cardeau-Desangles I; Rostaing L
Transplant Proc; 2010 Nov; 42(9 Suppl):S29-31. PubMed ID: 21095447
[TBL] [Abstract][Full Text] [Related]
6. Belatacept: a new biologic and its role in kidney transplantation.
Su VC; Harrison J; Rogers C; Ensom MH
Ann Pharmacother; 2012 Jan; 46(1):57-67. PubMed ID: 22215686
[TBL] [Abstract][Full Text] [Related]
7. Belatacept: a novel biologic for maintenance immunosuppression after renal transplantation.
Martin ST; Tichy EM; Gabardi S
Pharmacotherapy; 2011 Apr; 31(4):394-407. PubMed ID: 21449628
[TBL] [Abstract][Full Text] [Related]
8. Belatacept utilization recommendations: an expert position.
Grinyó JM; Budde K; Citterio F; Charpentier B
Expert Opin Drug Saf; 2013 Jan; 12(1):111-22. PubMed ID: 23206310
[TBL] [Abstract][Full Text] [Related]
9. Belatacept: a new era of immunosuppression?
El-Charabaty E; Geara AS; Ting C; El-Sayegh S; Azzi J
Expert Rev Clin Immunol; 2012 Aug; 8(6):527-36. PubMed ID: 22992146
[TBL] [Abstract][Full Text] [Related]
10. Challenges and opportunities in targeting the costimulation pathway in solid organ transplantation.
Wojciechowski D; Vincenti F
Semin Immunol; 2011 Jun; 23(3):157-64. PubMed ID: 21856169
[TBL] [Abstract][Full Text] [Related]
11. Costimulation blockade with belatacept in renal transplantation.
Vincenti F; Larsen C; Durrbach A; Wekerle T; Nashan B; Blancho G; Lang P; Grinyo J; Halloran PF; Solez K; Hagerty D; Levy E; Zhou W; Natarajan K; Charpentier B;
N Engl J Med; 2005 Aug; 353(8):770-81. PubMed ID: 16120857
[TBL] [Abstract][Full Text] [Related]
12. Beyond calcineurin inhibitors: emerging agents in kidney transplantation.
Safa K; Riella LV; Chandraker A
Curr Opin Nephrol Hypertens; 2013 Nov; 22(6):689-97. PubMed ID: 24100221
[TBL] [Abstract][Full Text] [Related]
13. Costimulatory blockade with belatacept in clinical and experimental transplantation - a review.
Emamaullee J; Toso C; Merani S; Shapiro AM
Expert Opin Biol Ther; 2009 Jun; 9(6):789-96. PubMed ID: 19426116
[TBL] [Abstract][Full Text] [Related]
14. Advances in immunosuppression for kidney transplantation: new strategies for preserving kidney function and reducing cardiovascular risk.
Bestard O; Campistol JM; Morales JM; Sánchez-Fructuoso A; Cabello M; Cabello V; Pallardó LM; Grinyó JM
Nefrologia; 2012 May; 32(3):374-84. PubMed ID: 22535159
[TBL] [Abstract][Full Text] [Related]
15. Belatacept-based regimens versus a cyclosporine A-based regimen in kidney transplant recipients: 2-year results from the BENEFIT and BENEFIT-EXT studies.
Larsen CP; Grinyó J; Medina-Pestana J; Vanrenterghem Y; Vincenti F; Breshahan B; Campistol JM; Florman S; Rial Mdel C; Kamar N; Block A; Di Russo G; Lin CS; Garg P; Charpentier B
Transplantation; 2010 Dec; 90(12):1528-35. PubMed ID: 21076381
[TBL] [Abstract][Full Text] [Related]
16. Belatacept in kidney transplantation.
Wojciechowski D; Vincenti F
Curr Opin Organ Transplant; 2012 Dec; 17(6):640-7. PubMed ID: 23044530
[TBL] [Abstract][Full Text] [Related]
17. Profile of belatacept and its potential role in prevention of graft rejection following renal transplantation.
Gupta G; Womer KL
Drug Des Devel Ther; 2010 Dec; 4():375-82. PubMed ID: 21151624
[TBL] [Abstract][Full Text] [Related]
18. Are calcineurin inhibitors-free regimens ready for prime time?
Vincenti F
Kidney Int; 2012 Nov; 82(10):1054-60. PubMed ID: 22622502
[TBL] [Abstract][Full Text] [Related]
19. T-cell co-stimulatory blockade in transplantation: two steps forward one step back!
Riella LV; Sayegh MH
Expert Opin Biol Ther; 2013 Nov; 13(11):1557-68. PubMed ID: 24083381
[TBL] [Abstract][Full Text] [Related]
20. Belatacept: in adult kidney transplant recipients.
Garnock-Jones KP
BioDrugs; 2012 Dec; 26(6):413-24. PubMed ID: 22928660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
